Tender Advertisement #1208660
This Opportunity Has ClosedThis opportunity has already closed and is no longer open for submissions.
Brief
Mushrooms as a cholesterol lowering food
Contract #
MU20001Location
EverywhereClosed On
Wed 16/06/2021 - 05:00 PM AESTTender Details
Horticulture Innovation Australia (Hort Innovation) is a not-for-profit, grower-owned Research and Development Corporation (RDC) for Australia’s $15.1 billion horticulture industry. Hort Innovation is a not-for-profit, grower-owned Research and Development Corporation (RDC) for Australia’s $15.1 billion horticulture industry. Hort Innovation invests around $120 million in research and development (R&D) and marketing programs annually to provide benefit to industry and the wider community.
Hort Innovation is seeking a suitably qualified, experienced and capable delivery partner for the project: Mushrooms and their potential health benefits of lowering blood cholesterol (MU20001).
The objectives of the project are to be delivered in two phases:
Phase one:
1. Profile beta-glucan levels in dry and wet tissue weight for three main mushroom varieties in the Australian market including: Agaricus bisporus (button, cup, flat and brown mushroom) as well as exotic mushroom varieties including shiimeji and oyster (Pleurotus).
2. Compare the mode of action for beta-glucan in mushrooms to that in oats to establish if they function in the same way to reduce human blood cholesterol.
Phase two:
• If the beta-glucan molecule in mushrooms is identified to be similar to oats, apply to FSANZ as per section 3.2.6 of the FSANZ Application Handbook to amend the high-level health claim in schedule 4 to vary claim conditions for beta-glucan.
• Recommend strategies and linkages to relevant R&D investments and the mushroom marketing program to disseminate and promote the beta-glucan health claim in mushrooms to promote their health benefits.
Hort Innovation has prepared a Request for Proposal (RFP) document that provides background information, outlines the scope of services, the procurement process and the information required from interested parties.
The RFP may be downloaded from www.tenders.net (you will need to be a member of tenders.net to access this information).
The closing date for responses is 16th June 2021, 5:00PM (AEST).
Hort Innovation is seeking a suitably qualified, experienced and capable delivery partner for the project: Mushrooms and their potential health benefits of lowering blood cholesterol (MU20001).
The objectives of the project are to be delivered in two phases:
Phase one:
1. Profile beta-glucan levels in dry and wet tissue weight for three main mushroom varieties in the Australian market including: Agaricus bisporus (button, cup, flat and brown mushroom) as well as exotic mushroom varieties including shiimeji and oyster (Pleurotus).
2. Compare the mode of action for beta-glucan in mushrooms to that in oats to establish if they function in the same way to reduce human blood cholesterol.
Phase two:
• If the beta-glucan molecule in mushrooms is identified to be similar to oats, apply to FSANZ as per section 3.2.6 of the FSANZ Application Handbook to amend the high-level health claim in schedule 4 to vary claim conditions for beta-glucan.
• Recommend strategies and linkages to relevant R&D investments and the mushroom marketing program to disseminate and promote the beta-glucan health claim in mushrooms to promote their health benefits.
Hort Innovation has prepared a Request for Proposal (RFP) document that provides background information, outlines the scope of services, the procurement process and the information required from interested parties.
The RFP may be downloaded from www.tenders.net (you will need to be a member of tenders.net to access this information).
The closing date for responses is 16th June 2021, 5:00PM (AEST).
This information is not guaranteed to be accurate or complete. Please confirm all details with the Tendering Firm before responding.
Powered by Tenders.Net - Inventors Of E-Tendering